What is the recommended daily dose of aspirin (acetylsalicylic acid) for antiplatelet therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Aspirin Dosage for Antiplatelet Therapy

For antiplatelet therapy, a daily aspirin dose of 75-100 mg is recommended for long-term maintenance therapy based on the most recent guidelines. 1

Initial Loading Dose vs. Maintenance Dose

Initial Loading Dose

  • For acute coronary syndromes (ACS) or situations requiring immediate antithrombotic effect:
    • Loading dose of 162-325 mg should be administered 1
    • Aspirin should be chewed (non-enteric coated) when possible for faster onset of action 1
    • This higher initial dose ensures rapid and complete inhibition of thromboxane A2-dependent platelet aggregation 1

Maintenance Dose

  • After initial loading, transition to a daily maintenance dose of 75-100 mg 1
  • This lower maintenance dose:
    • Is equally effective as higher doses for preventing cardiovascular events 2
    • Has significantly lower risk of gastrointestinal bleeding complications 2
    • Exceeds the minimal effective dose required for platelet thromboxane A2 suppression 1

Specific Clinical Scenarios

Acute Coronary Syndrome

  • Initial loading: 162-325 mg
  • Maintenance: 75-100 mg daily 1
  • When used with ticagrelor, aspirin dose should always be ≤100 mg daily 1

Post-PCI with Stent Placement

  • For first 3-6 months after drug-eluting stent (DES): 75-100 mg daily with clopidogrel 75 mg daily 1
  • After 12 months: Single antiplatelet therapy with aspirin 75-100 mg daily 1

Medical Management of ACS (without revascularization)

  • Maintenance: 75-100 mg daily with P2Y12 inhibitor for at least 12 months 1

Post-CABG for ACS

  • P2Y12 inhibitor therapy should be resumed after CABG with aspirin 75-100 mg daily to complete 12 months of dual antiplatelet therapy 1

Evidence Supporting Lower Maintenance Doses

The CURRENT-OASIS trial directly compared higher-dose (≥300 mg/day) versus low-dose aspirin (75-81 mg/day) in over 25,000 ACS patients and found similar efficacy outcomes between the two dosing strategies, but with increased bleeding risk at higher doses 2, 3.

Multiple guidelines consistently recommend the 75-100 mg daily maintenance dose based on:

  1. Equal efficacy compared to higher doses 2
  2. Significantly lower risk of gastrointestinal bleeding 2
  3. Sufficient platelet inhibition at this dose range 1

Common Pitfalls to Avoid

  • Using unnecessarily high maintenance doses: Higher maintenance doses (>100 mg) do not provide additional cardiovascular protection but increase bleeding risk 2
  • Failing to provide an adequate loading dose: In acute settings, a loading dose of 162-325 mg is necessary for rapid platelet inhibition 1
  • Using enteric-coated aspirin in acute settings: Non-enteric coated aspirin should be used and chewed when possible for faster onset of action in acute settings 1
  • Inappropriate dosing with ticagrelor: When using ticagrelor, aspirin dose should always be ≤100 mg daily 1

In conclusion, while an initial loading dose of 162-325 mg is appropriate in acute settings, the optimal maintenance dose of aspirin for antiplatelet therapy is 75-100 mg daily, which provides effective cardiovascular protection while minimizing bleeding risk.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.